The application letter provides the application for providing N - (4 - (4 - (4-amino-7 - (1-isobutirilpipiriridin-4-il) (1-isobuililpipiriridin-4-il) (1-isobuililpipiriridin-4-il) pirferro [1,2-f] [1,2,4,4] triazin-5-il-5-il) phenyl-phenyl-phenyl-1-isopropyl-2,4-dioxin-3 - (pyridin-2,3,3,4,4,4-tetra-tetra-tetrahydroppyridin- 5-5-carboxamid and N - (4 - (4-amin-7-- [1,1,1,1-pyripyridin-methyl-1,1,1,1,1-pyridin-1,1,1-1-pyridin-1,1-1 1,1,1] - Pyr pyr-1,1,1,1,1,1,1,1,1,1 - [Pyr 2,4) trioctyl-5-phenyl-1-isopropyl-2,4-dioxo-3-phenyl-1,2,3, 4-tetrahydropyridine-5-aminomethylamine can be used as TAM cinnamon inhibitor and related intermediate and process.La presente solicitud proporciona formas de sal de N-(4-(4-Amino-7-(1-isobutirilpiperidin-4-il)pirrolo[1,2-f][1,2,4]triazin-5-il)fenil)-1-isopropil-2,4-dioxo-3-(piridin-2-il)-1,2,3,4-tetrahidropirimidina-5-carboxamida y N-(4-(4-Amino-7-(1-isobutirilpiperidin-4-il)pirrolo[1,2-f][1,2,4]triazin-5-il)fenil)-1-isopropil-2,4-dioxo-3-fenil-1,2,3,4-tetrahidropirimidina-5-carboxamida, que son útiles como inhibidores de cinasas TAM, así como procesos e intermedios relacionados con estas.
